Meeder Asset Management’s Surmodics SRDX Stock Holding History

Meeder Asset Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11	Closed	–	–	1844
2022 Q3	$0	Sell	11 -37	-77%	-$1.27K	﹤0.01%	2358
2022 Q2	$2K	Sell	48 -2	-4%	-$78	﹤0.01%	1925
2022 Q1	$2K	Buy	+50	New	+$2.19K	﹤0.01%	2079
2021 Q4	–	Sell	-18	Closed	-$1K	–	2184
2021 Q3	$1K	Buy	18 +5	+38%	+$278	﹤0.01%	2371
2021 Q2	$1K	Hold	13	–	–	﹤0.01%	2391
2021 Q1	$1K	Hold	13	–	–	﹤0.01%	2262
2020 Q4	$1K	Hold	13	–	–	﹤0.01%	1737
2020 Q3	$1K	Buy	13 +3	+30%	+$132	﹤0.01%	2049
2020 Q2	$0	Buy	+10	New	+$379	﹤0.01%	2441
2019 Q1	–	Sell	-101	Closed	-$5K	–	1841
2018 Q4	$5K	Hold	101	–	–	﹤0.01%	1416
2018 Q3	$8K	Sell	101 -32	-24%	-$2.2K	﹤0.01%	1217
2018 Q2	$7.34K	Buy	133 +99	+291%	+$4.57K	﹤0.01%	1181
2018 Q1	$1K	Hold	34	–	–	﹤0.01%	1478
2017 Q4	$1K	Buy	+34	New	+$1.04K	﹤0.01%	1589

Other funds holding SRDX

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Meeder Asset Management's SRDX Position: Q4 2022 in Review

Meeder Asset Management sold out of Surmodics (SRDX) in Q4 2022, closing a stake of 11 shares.

Meeder Asset Management first reported a position in SRDX in Q4 2017 and held it in 14 quarters. The position peaked at $8K in Q3 2018. 121 funds tracked by Wall St. Rank hold SRDX as of Q4 2022.

Meeder Asset Management reported no remaining Surmodics position as of Q4 2022 after selling out during the quarter.
Meeder Asset Management sold 11 Surmodics shares in Q4 2022.
Meeder Asset Management first reported a position in Surmodics in Q4 2017 and held it in 14 quarters.
Meeder Asset Management's Surmodics position peaked at $8K in Q3 2018.
121 funds tracked by Wall St. Rank held Surmodics as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.